ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Commission Surveying for Pill, Hepatoma Association

October 1, 1976

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Obituary: Lawrence Garfinkel, ACS Epidemiologist

January 22, 2010